Key result
Cancer is linked to ~72% higher all-cause mortality following transcatheter mitral valve repair.
Why the study?
The impact of surgical and transcatheter mitral valve interventions in patients with active or prior cancer remains poorly characterized.
Meta-Analysis (n=6,238)
Answers are grounded in this paper and cite their sources.
Meta-analysis reveals increased all-cause mortality after transcatheter mitral valve repair in cancer patients, highlighting the need for tailored risk assessment.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Biondi et al. (2026) conducted a meta-analysis in Mitral regurgitation (n=6,238). Cancer vs. Controls (without cancer) was evaluated on All-cause mortality (HR 1.72, 95% CI 1.03-2.90). In patients undergoing transcatheter mitral valve repair, cancer was associated with a higher risk of all-cause mortality during follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: